Cointime

ExoCoBio

company

About

ExoCoBio has been developing innovative therapeutics as well as cosmetic products based on stem cell-derived exosomes.

  • 11 - 50

Highlights

Total Funding Amount
$47M
Funding Rounds
3
Investors
5

Details

Last Funding Type
Series C
Last Funding Money Raised
$9.30M
Industries
Biotechnology,Cosmetics,Health Care,Pharmaceutical
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

ExoCoBio has been developing innovative therapeutics as well as cosmetic products based on stem cell-derived exosomes.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$47M
ExoCoBio has raised a total of $47M in funding over 2 rounds. Their latest funding was raised on Aug 25, 2020 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 25, 2020 Series C $9.30M 1 — — Detail
Sep 12, 2018 Series B $26.70M 3 — — Detail
May 2, 2017 Series A $11M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
5
ExoCoBio is funded by 5 investors. Focus Assets Management and Seven Tree Equity Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Focus Assets Management — Series C
Seven Tree Equity Partners — Series B
GU Equity Partners — Series B
CSQUARED — Series B
ID Ventures — Series A
Cointime
เนื้อหา
บริษัท